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ABSTRACT 
Objective: This study determined the level of prescribers’ adherence to the World Health Organization/International Society of Hypertension 
(WHO/ISH) guidelines for the management of hypertension at the Lagos University Teaching Hospital (LUTH), Nigeria.  
Methods: This study employed a retrospective cross-sectional design. Two groups were used: Group A (300 patients) were treated before the 
guidelines review in 2003, while Group B (200 patients) were treated after. The two study groups were compared, and systolic blood pressure of 
130 mm Hg or above was taken as the index of hypertension. 
Results: There were 198 (66%) male patients in Group A, while Group B had 136 (68%) males. The highest age for Group A was 50–59 y for 89 
(30%) patients, unlike group B that had 58 (29%) patients in aged 40–49 y as the highest. The highest blood pressure range for patients in Group A 
was 150–159 mm Hg for 64 (21%) patients, unlike Group B that had 43 (22%) patients as the highest in the same range. Furosemide was present in 
282 (24%) prescriptions for group A patients. However, atenolol was present in 61 (20%) prescriptions for the same group. In group B, Furosemide 
was prescribed in 197 (97%) encounters, while Nifedipine was found in 81(40%) prescriptions.  
Conclusion: Prescribers at LUTH complied substantially with WHO/ISH guidelines in the management of hypertension. Diuretics and beta-blockers 
were used before the guideline review. After the review, diuretics and calcium channel blockers were the most frequently prescribed 
antihypertensives.  
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INTRODUCTION 
Hypertension is unarguably a vital health concern worldwide 
despite the recent advances in the management of the disease. It 
is a severe medical condition that significantly increases the 
chances of having the diseases of vital organs like kidney, brain, 
and heart.  
Almost 1.13 billion individuals all over the world are hypertensive, 
and two-thirds are found in low and average income nations [1]. The 
least prevalence is in rural India (6.8% in females and 3.4% in 
males), while the highest prevalence is in Poland (72.5% in females 
and 68.9% in males) [2]. In 2015, one in four males and one in five 
females had hypertension. According to the World Health 
Organisation, it plans to reduce the prevalence of hypertension and 
other non-communicable diseases by 25% in 2025 [1]. 
According to the International Society of Hypertension (ISH), 
hypertension predisposes Africans at higher risk of other diseases 
than individuals of different continents. In Africans, increased blood 
pressure is 3 to 5 times more likely to cause renal complications 
than the same level of elevation in blood pressure among individuals 
of Caucasian origin. However, Africans are more likely to be more 
sensitive to the intake of salt. They may not respond to treatment 
with Beta-blockers, Angiotensin Receptor Blockers (ARBs), and 
Angiotensin Receptor Enzymes inhibitors (ACEIs) [3].  
The ISH panel also defined hypertension based on pharmacological 
treatment anchored on the latest therapy cut-offs. For the patients in 
the age range of 18 to 79 y (adults), a systolic blood pressure ≥ 140 
mmHg, and a diastolic blood pressure level ≥ 190 mmHg that 
continues repeatedly could require the necessity for pharmacological 
treatment. However, in individuals above 80 y, the systolic blood 
pressure levels must be higher than 150 mmHg before any diagnosis 
can be confirmed. 
The ISH also advocates for the classification of hypertension into 
stages: 1 and 2. Stage 1 is levels 140-159/90-99 mmHg while 2 is 
≥160/>100 mmHg. The causes of hypertension are not fully 
understood. However, environmental and dietary parameters such as 
high intake of salt, dormant lifestyle, and obesity may aid the 
development of hypertension. There are so many genetic risk factors 
that may be implicated. Also, hypertensive patients that can be treated 
by the correction of hidden elements in the body system. However, 
less than 5% of all hypertensive patients belong to this category. 
The ISH guideline emphasizes the need for detecting the intrinsic 
causative factors in some individuals [3]. Guidelines are essential 
considerations in clinical decisions. They ensure that differences in 
practice are reduced to the barest minimum. They also ensure 
appropriateness in therapy as well as to measure the quality of care [4]. 
The Joint National Committee (JNC 8) guidelines advise sustainable 
blood pressure goals and minimal use of different classes of 
antihypertensive medicines. The new guideline emphasizes the 
control of systolic blood pressure (SBP) and diastolic blood pressure 
(DBP) with comorbidity and age treatment cut-offs. Further 
recommendations were also introduced and designed to promote 
safer use of angiotensin receptor blockers (ARBs) and angiotensin-
converting enzyme (ACE) inhibitors. Also, in individuals who are 60 y 
or above and do not present with any chronic kidney disease or 
diabetes, the goal of the blood pressure should be<150/90 mmHg. In 
patients who are between 18 to 59 y without any diseased condition 
and in patients who are 60 y or older with co-morbidity, the new blood 
pressure goal should be<140/90 mmHg. In both classes of patients, 
the first and later lines of treatment should be reduced to 4 types of 
antihypertensive agents, namely calcium channel blockers (CCBs), 
Angiotensin Receptor Blockers (ARBs), thiazide diuretics, and ACE 
inhibitors. Second or third-line alternatives should either be 
combinations or higher doses of CCBs, ARBs inhibitors, and thiazide 
diuretics. Alpha and Beta-blockers are also later line alternatives. 
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In patients of African origin without chronic kidney diseases, thiazide 
diuretics and CCBs should be administered instead of ACE inhibitors. 
ARBs and ACE inhibitors are recommended in all hypertensive 
individuals having chronic kidney disorders irrespective of racial 
background. These are recommended as first-line drugs or in addition 
to first-line medications. ARBs and ACE inhibitors are not encouraged 
to be administered concurrently. Thiazide diuretics and CCBs should 
be administered instead of ARBs and ACE inhibitors in hypertensive 
patients who are 75 y and above with a malfunctioning kidney [5]. 
Since Nigeria is an African country and indigenously blacks, the 
government adopted the JNC 8 Guidelines since it categorically 
emphasized on the use of antihypertensives, agents on blacks. The 
objective of this study was to determine the level of prescribers’ 
adherence to the treatment guideline for the management of 
hypertension at the Lagos University Teaching Hospital. 
MATERIALS AND METHODS 
This was a cross-sectional study that involved the retrospective 
abstraction of 3 mo of information from the medical records of out-
patients at the Lagos University Teaching Hospital. The study was 
conducted at the Lagos University Teaching Hospital (LUTH). It is a 
tertiary healthcare institution that provides health care services not 
only to the university community but also to the entire country since 
referrals are often made from both the primary and secondary 
health care providers in the country. 
Sampling procedures 
Using the Raosoft sample size calculator, the data of a total of 500 
patients were used for the study. The systematic random sampling 
technique was used to retrieve every second folder, which met the 
eligibility criteria. There were 300 patients in Group A, and 200 in 
Group B. Group A were patients before the review. 
Eligibility criteria 
The eligibility criteria of the study included the data of the patients 
who were diagnosed with essential hypertension and patients 
receiving drug therapy before and after the review of the 
guidelines. Diabetic patients and patients with hypertension 
secondary to other underlying conditions were excluded from the 
study. 
Data collection 
The medical records were examined in the presence of a third party 
who represented the hospital. Data collection was carried out in a 
secure place and at times, dictated by the usual practice of the 
hospital authorities. Neither patients’ names nor other identifiers 
were entered into the assessment sheet. The data collection was 
solely about their hypertensive condition.  
All the data and information were extracted and written down in 
proforma. These were designed to be destroyed as soon as the 
research was completed. 
Data analysis 
The data were entered into Microsoft excel (2016), checked for 
correctness, and used for descriptive statistical analysis. Measures of 
central tendency such as frequency, percentage, mean, mode, and 
median were used to describe the collected data. 
Ethical considerations 
Ethical approvals for the study were obtained from the University of 
Bradford (Ethics Application E.291) and the Lagos University 
Teaching Hospital (ADM/DCST/HREC/13 71). All the information 
abstracted from the medical records of the out-patients were treated 
with confidentiality.  
RESULTS AND DISCUSSION 
Of the 300 patients whose records were used in Group A, 198 (66%) 
were males, while 136 (68%) of the 200 patients in Group B were of 
a similar gender. The model age of the patients in group A was 45y 
while it was 40 y in group B. Other socio-demographic 
characteristics of the patients are as indicated in table 1. 
 
Table 1: Socio-demographic characteristics of the patients 
Characteristics  Group A (N-300) Group B (N=200) 
n (%) n (%) 
Age Range   
30-39 38(13) 29(14) 
40-49 77(26) 58(29) 
50-59 89(30) 54(27) 
60-69 63(21) 35(18) 
70-79 26(8) 18(9) 
80-89 7(2) 6(3) 
Mean (median) 53(55) 50(50) 
Min (max) 35(85) 30(85) 
Gender    
Male  198(66) 136(68) 
Female 102(34) 64(32) 
Weight   
50-59 3(1) 4(2) 
60-69 256(85) 167(83) 
70-79 41(14) 29(15) 
Occupation   
Skilled 103(34) 71(36) 
Unstilled 197(66) 129(64) 
health-related 104(35) 70(35) 
Non-health related 196(65) 130(65) 
 
One (0.3%) patient in group A had a systolic blood pressure range of 
130-139 mmHg while none has such systolic blood pressure range in 
group B. Furosemide was prescribed for 282 (94%) patients in group 
A, while it was prescribed for 197 (97%) patients in group B. The 
distribution of the systolic blood pressure ranges and prescribed 
drugs for patients in the two groups are shown in table 2.  
Single antihypertensive was used for 183(61%) patients in 
Group A which none of the patients had a four-drug combination. 
For Group B, 67(33%) of the patients were prescribed two-drug 
Combination antihypertensives. In fig. 1, the number of drug 
combinations is shown for patients in Group A and Group B. 
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Table 2: Clinical characteristics of the patients in Group A and B 
Characteristics Group A (N-300) Group B (N=200) 
n (%) n (%) 
BP Range (mmHg)   
130-139 1(0.3) - 
140-149 63(21) 41(20) 
150-159 64|(21) 43(22) 
160-169 61(20) 40(20) 
170-179 61(20) 42(21) 
180-189 50(17.7) 34(17) 
Drugs prescribed  (N=445) (N=450) 
Furosemide  282(94) 197(97) 
Atenolol 61(20) 59(30) 
Nifedipine  50(16) 81(40) 
Propranolol  44(15) 75(37) 
Captopril 6(2) 16(8) 
Clonidine 1(0.3)  2(1) 
Bendrothiazide 1(0.3) 1(0.5) 
Methyldopa  - 19(9.5) 
 
 
Fig. 1: Number of antihypertensives per prescription 
 
DISCUSSION 
This study was conducted at the Lagos Teaching Hospital to determine 
the level of prescribers’ adherence to the World Health 
Organisation/International Society for Hypertension (WHO/ISH) 
hypertension treatment guidelines. Two groups were used for the study. 
Group A was patients before the guideline review, while group B was 
those after the guideline review. The two groups had more male patients 
than females. The modal age of group A patients was slightly higher than 
those of group B, although the difference was not significant. 
Furosemide was the most prescribed antihypertensive for both 
groups. Many of the patients in both groups had a single 
antihypertensive prescribed for their use. Furosemide and atenolol 
were the predominantly co-prescribed drugs before the guideline 
review. The prescription changed to furosemide and Nifedipine co-
prescription in compliance with the guideline review. In both 
instances, prescribers of antihypertensives in the studied hospital 
complied with the treatment guidelines before and after the review. 
The sociodemographic characteristics reported in this study seem to 
be unique compared to those of similar studies. In a survey researched 
in Nigeria by Odili et al. (2008), the age range, weight range, 
occupation, and health-related or non-health-related characteristics of 
the patients were categorically defined [4]. In that study, 501 case 
notes were retrieved for evaluation between a specified period and 
were assessed for adherence to the treatment guidelines. In the study, 
the prevalence of hypertension was highest in the second category. 
More women were affected with diagnostic mean SBP and DBP of 
163.721.9 mmHg and 100.113.2 mmHg, respectively. With 
antihypertensive treatment, the values of the SBP and DBP for females 
reduced to 132.311.5 mmHg and 83.27.5 mmHg while those of the 
male patients were 131.811.6 mmHg and 84.37.5 mmHg, 
respectively. It is essential to mention that unlike in is this present 
study, the patients were assessed with co-morbidities [4].  
Another study conducted in Nigeria by Ale et al. (2017) focused on the 
awareness of hypertension treatment guidelines among primary-care 
prescribers and its relationship to hypertension diagnosis [6]. In the 
study, the primary care physicians (PCP) were categorized into two 
groups of hypertension guideline aware (GA) and unaware (GU). 
Anonymous self-administered questionnaires were employed, which 
is strikingly different from this study. The study concluded that there 
is a knowledge gap between guideline recommendations and 
hypertension care in Nigeria, which is further increased by PCP's 
awareness of the guidelines. Consequently, popularizing hypertension 
treatment guidelines among PCP's significantly improves 
hypertension care and reduces the upsurge of the disease [6].  
In Zimbabwe, research by Basopo et al. (2017) assessed the 
prescribing practices for hypertensive patients in the private sector 
to verify whether it followed the national treatment guidelines. The 
majority of the populace in Zimbabwe seek medical care from the 
private sector. In the research, they reviewed the hypertension 
prescription claims made by a private insurance company within a 
specific period. 
The last claim made in the year based on the prescription was used 
on the assumption that is represented the patients’ current 
treatment. The prescription information was analyzed by comparing 
the drugs prescribed to those recommended in Zimbabwe's 7th 
Essential medicines list and standard treatment guidelines of 2015. 
Slightly over a thousand prescriptions were investigated, and most 
patients were either placed on a single or double therapy. 
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ACEI/Angiotensin receptor blockers were the most prescribed 
agents (63 times), unlike in this study that had diuretics. Only 358 
(35%) prescriptions complied with guidelines, which indicates poor 
compliance [7]. The findings of the study are similar to those found 
in other countries, as was in the present study [8, 9].  
A similar study that was conducted in India by Varankanthan et al. 
(2018) had all the patients higher than 25 y of age. Five hundred and 
fifty hypertensive patients were used for the retrospective cross-
sectional study. In the study which was researched at a tertiary care 
government hospital, it was observed that there was a significant 
rise in the use of single therapy (from 56.9% to 82.5%, p<0.01). 
Also, the use of Beta Blocker (βB) moved from the first to the last 
position following JNC8 guidance. The thiazide diuretics were the 
least prescribed medicine, thus deviating from the JNC guidelines. 
They concluded that the combination therapy regimen must be 
followed as stipulated in the guidelines for the achievement of 
appropriate blood pressure goals [10]. It should, however, be noted 
that combination therapies predispose patients to drug therapy 
problems, especially drug-drug interactions [11, 12]. 
Also, in India, another prospective observational study was 
researched among 101 patients from different inpatient wards who 
were above the age of eighteen. The study also had patients with co-
morbidities. Calcium channel blocker was the most prescribed drug, 
while a few of the patients (15.84%) were placed on a combination 
regimen. The study also concluded that there was 50% adherence, 
which could be improved upon to enhance treatment outcomes [13].  
Sessioms et al. (2015) also evaluated the adherence to national 
guidelines for the treatment of hypertensive individuals who are of 
Africa-America descent. It was a descriptive pre-experimental 
quantitative study. Electronic medical records were investigated, 
and data were obtained from only 62 records of information. Blood 
pressure readings, laboratory studies, and other relevant data were 
collected. At the end of the study, the overall provider adherence 
was adjudged to be very good (75%) [14].  
Heneghan et al. (2008) researched general practitioners' awareness 
of present hypertension treatment guidelines and the 
implementation in their clinical practices. It was a questionnaire-
based survey via the internet, unlike this study that manually 
abstracted medical information was used. In the study, the 
awareness of the recommendation was high, but specified 
limitations and actions were required to enhance application and 
the guidelines that differ from the clinical effects. They concluded 
that increased adherence requires a dynamic workforce that 
matches the scientific evidence underlining the guidance [15]. 
Milchak et al. (2004), in their literature on the adherence to practice 
guidelines for the treatment of hypertension, stated that most of the 
studies have methodological limitations that hindered the 
physician's adherence [16].  
In cross-sectional research conducted in Malaysia by Ahmad et al. 
(2013) had 650 established hypertensive outpatients. The 
prescriptions were classified as compliant or non-compliant. The 
blood pressure (BP) recorded for the patients on the second visit 
was compared with the first visit. In the study, three hundred and 
forty-nine (67.1%) patients were guideline complaints. This implies 
that there was a significant level of adherence to treatment 
guidelines, which led to better management of hypertension [17].  
This study did not classify the classes of antihypertensive agents. 
Consequently, it is an apparent limitation. Another limitation is that 
the study is a one center study. However, being a teaching hospital, 
the research output could be dependable. Since the guidelines were 
reviewed in 2005, it's a limitation. However, the research gives an 
idea of a change of prescription pattern, which ultimately affects the 
adherence to the hypertension treatment guidelines. It also points to 
the need for pharmacists-led intervention in drug management of 
hypertension, as proven by an Indian study [18].  
CONCLUSION 
Prescribers at the Lagos University Teaching Hospital substantially 
complied with WHO/ISH hypertension treatment guidelines before 
and after the 2005 review. Before the review, Furosemide alone, in 
combination with atenolol, were the most commonly prescribed 
antihypertensives. Furosemide, with or without Nifedipine is the 
antihypertensives of choice after the review in the management of 
hypertension. Therefore, it is now recommended that continuous 
sensitization should be conducted to sustain and improve the 
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